Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mature dendritic cells are immune cells that act as highly efficient antigen-presenting cells (APCs), responsible for processing and presenting antigen fragments on their surface to T lymphocytes via MHC molecules, thereby initiating and regulating adaptive immune responses. Their maturation involves upregulation of co-stimulatory molecules (CD80, CD86, CD83), migration to lymphoid organs, and secretion of cytokines that guide T cell activation and differentiation. This function is central both to promoting immunity against pathogens and tumors and in maintaining tolerance to self-antigens. In clinical settings, mature dendritic cells are targeted in vaccine design and immunotherapy, highlighting their significance as both effectors and modulators in immunological disease contexts.
Enhancement of antigen presentation, modulation of DC maturation, and T cell priming and activation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell (mature, antigen-presenting function) (DC (not specific for this function, but commonly used for "Dendritic cell")).